GSK halts RSV vaccine trials in pregnant women after pause

It looks like GlaxoSmithKline’s concerns about its respiratory syncytial virus (RSV) vaccine in pregnant women aren’t going to be resolved quickly.

After suspending three trials of the much-anticipated vaccine earlier this month to investigate a safety signal, the pharma group has now gone a step further, stopping all enrolment and vaccination in the studi